Comment
doi: 10.4103/0366-6999.172611.
Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
Affiliations
- PMID: 26712449
- PMCID: PMC4797534
- DOI: 10.4103/0366-6999.172611
Item in Clipboard
Comment
Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
Chin Med J (Engl).
.
No abstract available
Figures
Forest plot of all-cause mortality in relation to risk of bias in trials. The size of squares for Mantel–Haenszel (M-H) risk ratio reflects the weight of trial in pooled analyses. Horizontal bars represent 95% confidence intervals. Results of a mixed effect analysis are shown. Pooled effect size and subgroup analyses are based on a fixed effects model using Comprehensive Meta-analysis version 2.2.064.
Comment in
-
Incomparable Subsequent Effects between Study and Control Fluids Might Cause Questionable Results in Randomized Controlled Trials.Chin Med J (Engl). 2016 Jan 5;129(1):117-8. doi: 10.4103/0366-6999.172612. Chin Med J (Engl). 2016. PMID: 26712450 Free PMC article. No abstract available.
Comment on
-
Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression.Chin Med J (Engl). 2015 Sep 5;128(17):2374-82. doi: 10.4103/0366-6999.163387. Chin Med J (Engl). 2015. PMID: 26315087 Free PMC article.
Similar articles
-
Incomparable Subsequent Effects between Study and Control Fluids Might Cause Questionable Results in Randomized Controlled Trials.Chin Med J (Engl). 2016 Jan 5;129(1):117-8. doi: 10.4103/0366-6999.172612. Chin Med J (Engl). 2016. PMID: 26712450 Free PMC article. No abstract available.
-
Hydroxyethyl starch 130/0.42 for bolus resuscitation in severe sepsis: long-term follow-up, confidence intervals and clinically important differences in outcomes.Intensive Care Med. 2014 Jul;40(7):1036-8. doi: 10.1007/s00134-014-3338-0. Epub 2014 May 20. Intensive Care Med. 2014. PMID: 24841701 No abstract available.
-
Protocols, physiology, and trials of hydroxyethyl starch.N Engl J Med. 2012 Sep 27;367(13):1266-7; author reply 1267. doi: 10.1056/NEJMc1209905. N Engl J Med. 2012. PMID: 23013091 No abstract available.
-
Starch safety in resuscitation - when will we ever learn?S Afr Med J. 2013 Apr 29;103(6):365-7. doi: 10.7196/samj.6969. S Afr Med J. 2013. PMID: 23725952 Review.
-
Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic Shock.Shock. 2016 Jul;46(1):17-26. doi: 10.1097/SHK.0000000000000577. Shock. 2016. PMID: 26844975 Free PMC article. Review.
Cited by
-
Effect of tetrastarch (hydroxyethyl starch 130/0.4) on plasma creatinine concentration in cats: a retrospective analysis (2010-2015).J Feline Med Surg. 2017 Oct;19(10):1073-1079. doi: 10.1177/1098612X16676160. Epub 2016 Nov 2. J Feline Med Surg. 2017. PMID: 27803312 Free PMC article.
References
-
- Zhu GC, Quan ZY, Shao YS, Zhao JG, Zhang YT. The study of hypertonic saline and hydroxyethyl starch treating severe (in Chinese) Chin Crit Care Med. 2011;23:150–3. - PubMed
-
- Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA. 2013;310:1809–17. doi: 10.1001/jama.2013.280502. - PubMed
-
- Perner A, Haase N, Wetterslev J. Mortality in patients with hypovolemic shock treated with colloids or crystalloids. JAMA. 2014;311:1067. doi: 10.1001/jama.2014.830. - PubMed
-
- Brun-Buisson C, Sun J, Natanson C. Mortality in patients with hypovolemic shock treated with colloids or crystalloids. JAMA. 2014;311:1068–9. doi: 10.1001/jama.2014.836. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
